Search research articles
Contact Us
Filters
Showing results (1381-1390 of 1,396) with videos related to
Page
of 140
Sort By:
The New England Journal of Medicine
|
April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
C Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Atherosclerosis
|
May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and Management
Florian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
The New England Journal of Medicine
|
September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure
|
November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
Stefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The New England Journal of Medicine
|
August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The Lancet Regional Health. Western Pacific
|
September 11, 2023
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
Nicholas W S Chew, Bryan Chong, Si Min Kuo, et al.
European Heart Journal
|
April 15, 2026
Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial
Prashanthan Sanders, Jonathan P Ariyaratnam, Martin K Stiles, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Thomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Journal of the American College of Cardiology
|
September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
Gemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy
Robert Kopajtich, Thomas J Nicholls, Joanna Rorbach, et al.
Page
of 140
Search research articles
Search
Showing results (1381-1390 of 1,396) with videos related to
Sort By:
Page
of 140
The New England Journal of Medicine
|
April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
C Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Atherosclerosis
|
May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and Management
Florian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
The New England Journal of Medicine
|
September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure
|
November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
Stefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The New England Journal of Medicine
|
August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The Lancet Regional Health. Western Pacific
|
September 11, 2023
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
Nicholas W S Chew, Bryan Chong, Si Min Kuo, et al.
European Heart Journal
|
April 15, 2026
Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial
Prashanthan Sanders, Jonathan P Ariyaratnam, Martin K Stiles, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Thomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Journal of the American College of Cardiology
|
September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
Gemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy
Robert Kopajtich, Thomas J Nicholls, Joanna Rorbach, et al.
Page
of 140